Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 4/2018

01-04-2018 | Original Article

Chemoprevention by Probiotics During 1,2-Dimethylhydrazine-Induced Colon Carcinogenesis in Rats

Authors: Sohini Walia, Rozy Kamal, D. K. Dhawan, S. S. Kanwar

Published in: Digestive Diseases and Sciences | Issue 4/2018

Login to get access

Abstract

Background

Probiotics are believed to have properties that lower the risk of colon cancer. However, the mechanisms by which they exert their beneficial effects are relatively unknown.

Aim

To assess the impact of probiotics in preventing induction of colon carcinogenesis in rats.

Methods

The rats were divided into six groups viz., normal control, Lactobacillus plantarum (AdF10)-treated, Lactobacillus rhamnosus GG (LGG)-treated, 1,2-dimethylhydrazine (DMH)-treated, L. plantarum (AdF10) + DMH-treated and L. rhamnosus GG (LGG) + DMH-treated. Both the probiotics were supplemented daily at a dose of 2 × 1010 cells per day. DMH at a dose of 30 mg/kg body weight was administered subcutaneously twice a week for the first 4 weeks and then once every week for a duration of 16 weeks. Glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx), glutathione-S-transferase (GST) and catalase as protein expression of genes involved in apoptosis were assessed during DMH-induced colon carcinogenesis in rats.

Results

DMH treatment decreased the activity of GSH, GPx, GST, SOD and catalase. However, AdF10 and LGG supplementation to DMH-treated rats significantly increased the activity of these enzymes. Further, DMH treatment revealed alterations in the protein expressions of various genes involved in the p53-mediated apoptotic pathway such as p53, p21, Bcl-2, Bax, caspase-9 and caspase-3, which, however, were shifted towards normal control levels upon simultaneous supplementation with probiotics.

Conclusion

The present study suggests that probiotics can provide protection against oxidative stress and apoptotic-related protein disregulation during experimentally induced colon carcinogenesis.
Literature
1.
Bray F, Jemal A, Grey N, et al. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol. 2012;13:790–801.CrossRefPubMed
2.
Martenson JA Jr, Willett CG, Sargent DJ, et al. Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of Intergroup Protocol 130. J Clin Oncol. 2004;22:3277–3283.CrossRefPubMed
3.
4.
5.
Verna EC, Lucak S. Use of probiotics in gastrointestinal disorders: what to recommend? Ther Adv Gastroenterol. 2010;3:307–319.CrossRef
6.
Chau I, Cunningham D. Adjuvant therapy in colon cancer—what, when and how? Ann Oncol. 2006;17:1347–1359.CrossRefPubMed
7.
Thirabunyanon M, Hongwittayakorn P. Potential probiotic lactic acid bacteria of human origin induce antiproliferation of colon cancer cells via synergic actions in adhesion to cancer cells and short-chain fatty acid bioproduction. Appl Biochem Biotechnol. 2013;169:511–525.CrossRefPubMed
8.
Walia S, Keshani Sood S, et al. Exhibition of DNA-bioprotective activity by microflora of traditional fermented foods of North-Western Himalayas. Food Res Int. 2014;55:176–180.CrossRef
9.
Jackson PE, O’Connor PJ, Cooper DP, et al. Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine. Carcinogenesis. 2003;24:527–533.CrossRefPubMed
10.
11.
Breimer LH. Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage. Mol Carcinog. 1990;3:188–197.CrossRefPubMed
12.
13.
Walia S, Kamal R, Kanwar SS, et al. Cyclooxygenase as a target for chemoprevention by probiotics during 1,2-dimethylhydrazine induced colon cancer. Nutr Cancer. 2015;67:603–611.CrossRefPubMed
14.
Sourabh A, Kanwar SS, Sharma OP. Antagonistic potential of indigenous bacterial probiotics of Western Himalayas against antibiotic-resistant bacterial pathogens. Curr Sci. 2011;101:1–6.
15.
16.
Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–169.PubMed
17.
Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys. 1978;186:189–195.CrossRefPubMed
18.
Luck H. Quantitative determination of catalase activity of biological material. Enzymologia. 1954;17:31–40.PubMed
19.
Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249:7130–7139.PubMed
20.
21.
Carlburg I, Mannervik B. Glutathione reductase. Methods Enzymol. 1985;113:484–490.CrossRef
22.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.CrossRefPubMed
23.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685.CrossRefPubMed
24.
Newell LE, Heddle JA. The potent colon carcinogen, 1,2-dimethylhydrazine induces mutations primarily in the colon. Mutat Res. 2004;564:1–7.CrossRefPubMed
25.
Saini MK, Kaur J, Sharma P, et al. Chemopreventive response of diclofenac, a non-steroidal anti-inflammatory drug in experimental carcinogenesis. Nutr Hosp. 2009;24:717–723.
26.
Mano T, Sinohara R, Sawai Y, et al. Changes in lipid peroxidation and free radical scavengers in the brain of hyper-and hypothyroid aged rats. J Endocrinol. 1995;147:361–365.CrossRefPubMed
27.
Huang YL, Sheu JY, Lin TH. Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin Biochem. 1999;32:131–136.CrossRefPubMed
28.
Samir M, el Kholy NM. Thiobarbituric acid reactive substances in patients with laryngeal cancer. Clin Otolaryngol Allied Sci. 1999;24:232–234.CrossRefPubMed
29.
Schmelz EM, Sullards MC, Dillehay DL, et al. Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1, 2-dimethylhydrazine-treated CF1 mice. J Nutr. 2000;130:522–527.CrossRefPubMed
30.
Cao G, Sofic E, Prior RL. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Bio Med. 1997;22:749–760.CrossRef
31.
Meister A. New aspects of glutathione biochemistry and transport-selective alteration of glutathione metabolism. Nutr Rev. 1984;42:397–410.CrossRefPubMed
32.
Kullisaar T, Songisepp E, Mikelsaar M, et al. Antioxidative probiotic fermented goats’ milk decreases oxidative stress-mediated atherogenicity in human subjects. Br J Nutr. 2003;90:449–456.CrossRefPubMed
33.
Farag IM, Abdel-Aziz KB, Nada SA, et al. Modulation of ochratoxin-induced oxidative stress, genotoxicity and spermatotoxic alterations by Lactobacillus rhamnosus GG in male albino mice. J Am Sci. 2010;6:575–587.
34.
Kyle ME, Miccadei S, Nakae D, et al. Superoxide dismutase and catalase protect cultured hepatocytes from the cytotoxicity of acetaminophen. Biochem Biophys Res Commun. 1987;149:889–896.CrossRefPubMed
35.
Matés JM, Sánchez-Jiménez F. Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci. 1999;4:D339–D345.CrossRefPubMed
36.
Yasuda E, Serata M, Sako T. Suppressive effect on activation of macrophages by Lactobacillus casei strain Shirota genes determining the synthesis of cell wall-associated polysaccharides. Appl Environ Microbiol. 2008;74:4746–4755.CrossRefPubMedPubMedCentral
37.
38.
Bruno-Bárcena JM, Andrus JM, Libby SL, et al. Expression of a heterologous manganese superoxide dismutase gene in intestinal lactobacilli provides protection against hydrogen peroxide toxicity. Appl Environ Microbiol. 2004;70:4702–4710.CrossRefPubMedPubMedCentral
39.
Shen H, Tsuchida S, Tamai K, et al. Identification of cysteine residues involved in disulfide formation in the inactivation of glutathione transferase P-form by hydrogen peroxide. Arch Biochem Biophys. 1993;300:137–141.CrossRefPubMed
40.
Gregor R, Andrew WB. Selection of lactobacillus strains for urogenital probiotic applications. J Infect Dis. 2001;183:S77–S80.CrossRef
41.
Manju V, Balasubramaniyan V, Nalini N. Rat colonic lipid peroxidation and antioxidant status: the effects of dietary luteolin on 1, 2-dimethylhydrazine challenge. Cell Mol Biol Lett. 2005;10:535–551.PubMed
42.
Payne D, Kubes P. Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability. Am J Physiol. 1993;265:G189–G190.PubMed
43.
Kumar M, Kumar A, Nagpal R, et al. Cancer-preventing attributes of probiotics: an update. Int J Food Sci Nutr. 2010;61:473–496.CrossRefPubMed
44.
Giaccia AJ, Kastan MB. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 1998;12:2973–2983.CrossRefPubMed
45.
Lohrum MA, Vousden KH. Regulation and activation of p53 and its family members. Cell Death Differ. 1999;6:1162–1168.CrossRefPubMed
46.
Jin S, Levine AJ. The p53 functional circuit. J Cell Sci. 2001;114:4139–4140.PubMed
47.
Hilska M, Collan YU, Laine VJO, et al. The significance of tumor markers for proliferation and apoptosis in predicting survival in colorectal cancer. Dis Colon Rectum. 2005;48:2197–2208.CrossRefPubMed
48.
Resnick MB, Routhier J, Konkin T, et al. Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study. Clin Cancer Res. 2004;10:3069–3075.CrossRefPubMed
49.
50.
Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2010;2:a001008.CrossRefPubMedPubMedCentral
51.
Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 1995;80:293–299.CrossRefPubMed
52.
Sedlak TW, Oltvai ZN, Yang E, et al. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci USA. 1995;92:7834–7838.CrossRefPubMedPubMedCentral
53.
Zha H, Reed JC. Heterodimerization-independent functions of cell death regulatory proteins Bax and Bcl-2 in yeast and mammalian cells. J Biol Chem. 1997;272:31482–31488.CrossRefPubMed
54.
Xiang J, Chao DT, Korsmeyer SJ. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc Natl Acad Sci USA. 1996;3:14559–14563.CrossRef
55.
Skulachev VP. Cytochrome c in the apoptotic and antioxidant cascades. FEBS Lett. 1998;423:275–280.CrossRefPubMed
56.
Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322–1326.CrossRefPubMed
Metadata
Title
Chemoprevention by Probiotics During 1,2-Dimethylhydrazine-Induced Colon Carcinogenesis in Rats
Authors
Sohini Walia
Rozy Kamal
D. K. Dhawan
S. S. Kanwar
Publication date
01-04-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-4949-z

Other articles of this Issue 4/2018

Digestive Diseases and Sciences 4/2018 Go to the issue

Original Article

Evaluation of the International Consensus Guidelines for the Surgical Resection of Intraductal Papillary Mucinous Neoplasms

Original Article

Proton Pump Inhibitors Increase the Susceptibility of Mice to Oral Infection with Enteropathogenic Bacteria

Original Article

Effect of Bifidobacterium infantis 35624 (Align) on the Lactulose Breath Test for Small Intestinal Bacterial Overgrowth

Correspondence

Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology

Concise Commentary

Concise Commentary: Presurgical Evaluation of IPMNs—Eight Is Enough

Original Article

Clinicopathology and Survival in Patients with Gastroesophageal Reflux After Radical Surgery of Proximal Gastric Cancer
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits